Funding for this research was provided by:
Novo Nordisk
Article History
Accepted: 26 June 2020
First Online: 3 July 2020
Compliance with Ethical Standards
: This project involved publicly accessible de-identified data and thus did not meet our University’s definition for human subject research.
: Dr. Wong receives research support from Novo Nordisk, Boehringer-Ingelheim, Amarin, Amgen, and Novartis, has served on an advisory board for Esperion, and is on the speakers bureau for Amarin and Sanofi. No other authors have any disclosures.